Benjamin Graham fit · Inversión deep-value defensiva
Is Halozyme Therapeutics, Inc. (HALO) a Benjamin Graham Stock?
Meets 3/7 Graham criteria — partially qualifies.
46/100
DSeñales mixtas
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a HALO
P/E ≤ 15
clave—
P/B ≤ 1.5
clave15.0x
Current ratio ≥ 2
1.6x
Debt / Equity ≤ 1
0.0x
Cómo se valora HALO en otras estrategias
Datos financieros en vivo
Cap. mercado
$8.38B
PER (TTM)
20.4x
ROIC (TTM)
22.84%
Margen bruto
84.55%
Preguntas frecuentes
What is HALO's Benjamin Graham fit score?
HALO scores 46/100 on our Benjamin Graham fit engine — grade D. Meets 3/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own HALO?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends HALO.
How often is this score updated?
HALO's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende HALO personalmente.